PF

Pagliuca Family Office

North America, Massachusetts, United States, Boston

Description

Pagliuca Family Office

Investor Profile

Pagliuca Family Office has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series C (33%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Oncology
  • Pharmaceutical
  • Commercial Real Estate
  • Enterprise Software
  • Mobile Apps
  • Real Estate
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pagliuca Family Office frequently co-invest with?

PureTech Health
North America, Massachusetts, United States, Boston
Co-Investments: 1
Allegion Ventures
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Accomplice
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
Cushman & Wakefield
North America, Illinois, United States, Chicago
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Pagliuca Family Office often collaborate with?

JS
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by Pagliuca Family Office?

HqO

Boston, Massachusetts, United States

HqO creates workplace experience technology that transforms how people connect with each other and the places they work.

Commercial Real EstateEnterprise SoftwareMobile AppsReal Estate
Series CApr 14, 2021
Amount Raised: $60,000,000
Vor Biopharma

Cambridge, Massachusetts, United States

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Series BJul 7, 2020
Amount Raised: $110,000,000
CorVent Medical

Fargo, North Dakota, United States

We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.

Health CareMedical
SeedMay 11, 2020
Amount Raised: $4,500,000